Concepedia
Statistics
Publications
12
Citations
1.4K
H-Index
11
Active since
2002
Affiliations
Emory University(Current)
Vertex Pharmaceuticals (United States)
Cystic Fibrosis Trust
Centers for Disease Control and Prevention
Vertex Pharmaceuticals (United Kingdom)
Nataliya Volkova is an author at Emory University specializing in medicine, nephrology, and renal disease.
Publications per year
2002–2023
Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries
Nataliya Volkova, Kristin A. Moy, Jennifer Evans et al. · Journal of Cystic Fibrosis · 2019 · 255 citations
Medicine, Internal Medicine, Pharmacotherapy +14
Neighborhood Poverty and Racial Disparities in Kidney Transplant Waitlisting
Rachel E. Patzer, Sandra Amaral, Haimanot Wasse et al. · Journal of the American Society of Nephrology · 2009 · 217 citations · Full text
Medicine, Demography, Nephrology +15
Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor
Leona Bessonova, Nataliya Volkova, Mark Higgins et al. · Thorax · 2018 · 213 citations · Full text
Neighborhood Poverty and Racial Differences in ESRD Incidence
Nataliya Volkova, William McClellan, Mitchel Klein et al. · Journal of the American Society of Nephrology · 2007 · 193 citations
Public Health, Nephrology, Population Health Sciences +17
Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U.S. Hospitals
Scott K. Fridkin, Holly A. Hill, Nataliya Volkova et al. · Emerging infectious diseases · 2002 · 133 citations · Full text
Veterinary Medicine, Infectious Diseases, Antimicrobial Resistance +14
1–5 of 12